Chairs: Stanly Rockson, Stanford University and Kari Alitalo, University of Helsinki Guillermo Oliver, Northwestern University Transcriptional profiling of lymphatic endothelial cells Melody Swartz, University of Chicago Immune implications of
lymphangiogenesis in inflammation
Modulating ECM assembly to alter tumor vascular barrier function Weilan Ye, Genentech
Lymphangiogenesis and lymphatic endothelial barrier as targets in regenerative medicine Giorgia Jurisic, Novartis Wnt / beta - catenin signaling as a therapeutic target for blood - brain barrier repair in neurological disorders Dritan Agalliu, Columbia University Somatic mutations in hematopoietic cells contribute to cardiovascular disease: New mechanisms, new targets Kenneth Walsh, Boston University
Therapeutic stimulation of cardiac
lymphangiogenesis — protein vs. gene therapy approaches post-MI Ebba Brakenhielm, Rouen University
Adams, R. H. & Alitalo, K. Molecular regulation of angiogenesis and
lymphangiogenesis.
Glycolytic metabolism and VEGFR3 signaling are required for
lymphangiogenesis Joanna Chen, Hampton University
Research Interests: Inflammatory bowel disease (IBD); Crohn's disease; ulcerative colitis; animal models of IBD; mucosal T - cell death and survival; tolerance to gut microbiota; interactions between immune and non-immune cells; immune - driven angiogenesis and
lymphangiogenesis; intestinal fibrosis; intestinal myofibroblasts, extracellular matrix; systems biology; complex diseases